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Mitragyna ciliata (Aubrev and Pellegr) (Rubiaceae) is a plant commonly used in traditional medicine in Côte d'Ivoire for the malaria
treatment. This plant's extract was obtained by maceration of the powdered leaves in methanol. It was evaluated for its intrinsic antiplasmodial
activity, its ability to synergise in vitro the effect of chloroquine against drug-resistant Plasmodium falciparum FcM29 strain using isobologram
analysis. The cytotoxic activity was estimated on HeLa cells and the ratio of cytotoxicity/antimalarial activity calculated. As results; the IC50
values for the antiplasmodial activity were ranged from 14 to 44 μg/ml depending on incubation duration, strains or isolates tested. The extract
showed the reversal of chloroquine resistance in FcM29 strain. The mean cytotoxicity/antiplasmodial for this extract was determinated at 13.
© 2007 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Mitragyna ciliata; Plasmodium falciparum; Potentiation1. Introduction
Malaria remains the first severe parasitic disease particularly in
tropical and subtropical areas with the strongest mortality. More-
over, resistance to antipaludic has become a global problem, it
caused a renewed interest to research on the pharmacopeia plants
illustrated by the discovery of the artemisinin extracts from
Qinghao, (Azas et al., 2002; Ying and Yu-Lin, 1998).
In Côte d'Ivoire, some of the plants used in traditional medi-
cine as febrifuge were also evaluated for their intrinsic anti-
plasmodial activity (Benoit-Vical et al., 1998; Mustofa et al.,
2000). As for us, we are interested in Mitragyna ciliata (Aubrev
and Pellegr) (Rubiaceae).This plant has some important medic-
inal properties e.g. it is poisonous to paramecia and has analgesic⁎ Corresponding author. 12 BP 720 Abidjan 12 /, Côte d'Ivoire.
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d'Ivoire it is often used in traditional medicine for malaria
treatment. In the present study, our goal is to evaluate in vitro:
the intrinsic antiplasmodial activity of the methanolic extract of
M. ciliata, its ability to act synergistically with chloroquine
against chloroquine resistant Plasmodium falciparum.
2. Materials and methods
2.1. Plant extract
As in tropical and subtropical regions of Africa, M. ciliata is
found in swampy areas in Côte d'Ivoire where rainfall is over
1250 mm/year and the temperature between 25 °C and 35 °C.
Its leaves were collected and identified by comparison with
authentic specimens deposited in the botany laboratory her-
barium of the University of Abidjan-Cocody (n°8114). They
were cut out into small pieces, carefully washed with distilledts reserved.
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fifteen days before being crushed into semifine powder.
The technique of extraction is that of Philipson and O'neill
(1986) and of Agbaje and Onabanjo (1991) modified: 20 g of
the leaves dry powder are macerated into 400 ml of methanol
70% for 48 h by magnetic agitation without heating then,
filtered on paper whatman n°1. The filtrate is evaporated at
40 °C using Rotavapor Buchi and the brown deposit formed is
scraped using a spatula and then weighed (4.5 g); it represents
the leaves methanolic extract. A solution mother of this extract
is obtained by dissolving 7.5 mg of the extract into 30 μl of
methanol and 150 ml of RPMI 1640 added (Sigma chemical Co,
St Louis, Missouri, the USA). The alcohol level in the solution
mother is finally 0.02%.
Chloroquine sulfate (Aventis, Antony France) is used in this
study as reference.
2.2. Isolates and parasite strains
The P. falciparum isolates were taken by venipuncture on
ACD (acid citrate–dextrose) from outpatients with uncompli-
cated malaria before starting the treatment. The chloroquine
resistant strain FcM29 and the chloroquine sensitive strain Vial
maintained in continuous culture (Trager and Jensen, 1976)
were cultivated in group O humain erythrocytes and suspended
at a 4% hematocrit in RPMI 1640 supplemented with 25 mM
HEPES (Sigma chemical Co, the USA), 25 mM NaHCO3
(Merck Mannheim, Germany) and complemented with 10%
human serum. FcM29 strain was synchronized by flotation on
gelatin (Plasmagel, Roger Bellon, Paris, France) followed 4 h
later by 5% D-sorbitol lysis (Merck, Darmastadt Germany), Vial
strain was synchronized with 5% D-sorbitol only (Lambros and
Vanderberg, 1979).
2.3. Assay of antimalarial activity
The intrinsic antimalarial activity of the extract was
evaluated on synchronized P. falciparum strains FcM29, Vial
and P. falciparum chloroquine resistant and chloroquine sen-
sitive isolates. For each strain or isolate, the infected blood cells
were washed three times in RPMI 1640, and in vitro culture was
performed in triplicate in 24-well plates using the non isotopic
semi-microtest of LeBras and Deleron (1983). Each well
contained 700 μl of infected blood cells, RPMI 1640 supple-
mented with 25 mM HEPES, 25 mM NaHCO3, complemented
with 10% human serum. 25 μl of various concentrations of
either the extract or chloroquine were added in triplicate. In eachTable 1
Antimalarial activity and toxicity of the methanolic extract of M. ciliata on P. falcip
isolate(CQS) and on human fibroblasts line cells (HeLa)
FcM29 Vial
72 h 24 h 72 h
Methanolic extract of M. ciliata IC50 (μg/ml) 18±9 30±18 14±4
Chloroquine IC50 (nM/l) 250±32 235±12 37±3
ND=not determined.plate, three wells free from drugs and extract were considered as
controls. The plates were incubated in candle jar for 24 and 72 h
at 37 °C (hematocrit 4%, parasitemia 0.1%). After the expo-
sure time, the supernatant was removed from every well and
Giemsa stained thick film was performed with the cell layer to
determine the number of schizontes which were visual
counted for 100 parasites. These values were then expressed
as a percentage, relative to the control cultures without extract.
IC50 value were graphically determined (percent inhibition ver-
sus concentration).
2.4. Chloroquine and plant extract synergism assessment
Eight serial dilutions of chloroquine progressively doubled
from 12.5 to 1600 nM/l were distributed in triplicate in 24 well
plates in total volume of 25 μl per well. For the drug combi-
nations, each previous plate was charged with additional 25 μl
per well of one of the following subinhibitory concentration of
the plant extract (0.26, 0.52, 0.78 and 1.25 μg/ml). In each plate,
three wells free from drug and plant extract were considered as
control like other plates alternatively charged in chloroquine
alone or plant extract alone. The in vitro culture was carried out
according to Le Bras and Deleron (1983) described above.
Cultures were established from synchronized P. falciparum
FcM29 or Vial strains or isolates (hematocrit 4%, parasitemia
0.1%). The isolates were diluted with normal human erythro-
cytes group O when the parasitemia exceeded 8000 asexual
parasites/μl (N0.2%). The cultures were incubated at 37 °C for
42 h which were also the parasite-extract (or chloroquine or
combined extract-drug) exposure period, the experimentations
were repeated three times. The synergism between chloroquine
and methanolic extract of M. ciliata was assessed by isobolo-
gram analysis, the horizontal and vertical axis are the percent-
ages of the IC50 of chloroquine and plant extract respectively
i.e. the ratio IC50 of each combination/IC50 of chloroquine alone
and the ratio of each subinhibitory concentration/IC50 of plant
extract alone. Isobol is plotted in joining the points representing
the iso-effective doses of chloroquine and plant extract
combinations. The interpretation of the isobologram is defined
on the basis of the form of the curve: concave is synergism,
convex is antagonism and following the diagonal is additivity
(Azas et al., 2002).
2.5. Evaluation of cytotoxic activity
In vitro cytotoxicity of the extract was determined on human
fibroblast (HeLa) cells. Cells were distributed in 96-well platesarum FcM29, Vial, choloroquine-resistant isolate (CQR), chloroquine sensitive
Isolate CQR Isolate CQS HeLa cells
24 h 72 h 24 h 72 h 24 h 72 h 24 h
44±6 14±5 ND 15±5 ND 251±45 198±27
33±2 188±98 ND 52±23 ND N3200 N3200
Table 2
IC50 of the combinations chloroquine–M. ciliata extract on P. falciparum
chloroquine resistant isolates and FcM29 strain
Concentration of the plant
extract added (μg/ml)
IC50 (nM/l) of the combinations
chloroquine– extract
FcM29 Isolate CQR
0 256±28 173±11
0.26 237±9 32±3
0.52 98±5 24±1
0.78 87±6 24±1
1.25 48±3 23±2
CQR=chloroquine resistant.
Fig. 1. Isobologram of drugs interaction betwen chloroquine and M. ciliata in
FcM29 chloroquine resistant P. flaciparum strain.
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mented with 5% fetal calf serum (Boehringer, Germany), then
100 μl of culture medium containing extracts at various concen-
trations were added. Plates were incubated in candle jar for 24
and 72 h at 37 °C. After the incubation periods, HeLa cells were
removed from the plates by treatment with trypsin. The per-
centage of viable cells was established on microscope using
trypan blue and compared to a control culture free from
extract, then cell growth (IC50) was graphically determined
(percent survival versus concentration). Cytotoxic-antiplas-
modial ratio (IC50 HeLa cells versus IC50 against Plasmo-
dium) was determined.
Statistical analysis using the Chi squared test were performed
with Epi info 6.0 software and the significance level fixed at
pb0.05. The cell growth (CI50) graphics and isobologram
were determinated with Origin 6.0 software.
3. Results
The intrinsic antiplasmodial activity was ranged from
14 μg/ml to 18 μg/ml after 72 h incubation period. There was no
difference betwen chloroquine resistant and chloroquine sensitive
Plasmodium activity (p=0.55) (Table 1).
The chloroquine synergism assessment in FcM29 strain
showed that the extract subinhibitory dose of 1.25μg/ml combined
to chloroquine reduced 5 times the initial IC50 of this strain to
chloroquine, the Vial chloroquine sensitive strain didn't show any
significant modification ( p=0.14). The identical evaluation
carried out on the chloroquine resistant P. falciparum isolatesTable 3
IC50 of the combinations chloroquine–M. ciliata extract on P. falciparum
chloroquine sensitive isolates and Vial strain
Concentration of the plant
extract added (μg/ml)
IC50 (nM/l) of the combinations
chloroquine–extract
Vial Isolate CQS
0 37±3 39±8
0.26 44±1 30±16
0.52 35±5 unint.
0.78 29±7 23±0
1.25 36±3 21±2
unint=uninterpretable.also showed a significant modification of their IC50 ( p=0.01)
(Tables 2 and 3). The concave isobol indicated synergism and total
reversion of the chloroquine resistance in FcM29 strain (Fig. 1).
The methanolic extract of M. ciliata appeared to be toxic
with the mean cytotoxicity/antiplasmodial index determined at
13±6 (Table 1).
4. Discussion and conclusion
Some plant extracts also revealed their ability to reverse
chloroquine resistance. It is the case of the malagashanine, an
alkaloid extracted from Malagasy strychnos used in traditional
medicine in Madagascar (Rafatro et al., 2000). In the same
way, two alkaloïds: the tetrahydroharman and acid ursolic
extracted respectively from Guiera senegalensis (Combreta-
ceae), Mitragyna inermis (Rubiaceae) reverse resistance in
chloroquine resistanceW2 strain, each of the plants is associated
to another plant in traditional medicine in Mali (Azas et al.,
2002). Furthermore, it was reported that the combination of
extracts from Ekebergia capensis andClerodendrum myricoides
with chloroquine against the multidrug resistant P. falciparum
(V1/S) revealed respectively synergistic effect (Muregi et al.,
2004). Some molecules synthesized by chemical processes are
also synergistic to chloroquine such as 9,10-dihydroethano-
anthracene which reverses resistance in chloroquine resistance
isolates at 1/20 of its IC50 without significant modification of the
IC50 in chloroquine susceptible isolates tested (Millet et al.,
2004). We also reported the nonobservance of synergistic
interaction between chloroquine and M. ciliata methanolic
extract in chloroquine sensitive Vial strain, this strongly
suggests the synergistic ability of this plant extract as it was
confirmed by the concave isobologram. Many authors have
mentioned drug efflux out of chloroquine resistant parasites as
the mechanism of resistance, some maintain the existence of an
energy-dependent carrier that moves chloroquine out of the
parasite (Sanchez et al., 2003). Regarding this viewpoint, we can
suggest that extract could interfere with drug permeability and
reduce the efflux but our data don't permit us to describe the
exact mechanism of the synergism.
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d'ivoire for the malaria treatment. The combination of 1.25 μg/ml
of its methanolic extract to chloroquine strongly potentiates this
drug in resistant parasites. Additionally, this plant may be of
medical interest because its ability to reverse chloroquine re-
sistance with low doses could modulate its apparent toxicity. This
preliminary study and its data encourage us to focus future efforts
particularly on the compounds from this plant extract and to
investigate further on animal models for in vivo assessment.
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